Abstract
Tom Halper is not the only American who has been looking at the rationing of renal replacement therapy in the United Kingdom. All are appalled at the denial of effective lifesaving therapy to elderly and high-risk patients, such as diabetics, with end stage renal failure (1). Some realize that the rationing practiced in the United Kingdom today may have to be applied in other countries tomorrow (2). Medical resources are not unlimited (3).
Publisher
Cambridge University Press (CUP)